Orion Portfolio Solutions’s AstraZeneca AZN Stock Holding History

Orion Portfolio Solutions’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$11M	Buy	74,749 +164	+0.2%	+$23.7K	0.11%	175
2024 Q4	$9.77M	Sell	74,585 -8,385	-10%	-$1.17M	0.1%	201
2024 Q3	$12.9M	Sell	82,970 -2,664	-3%	-$430K	0.13%	158
2024 Q2	$13.4M	Buy	85,634 +12,663	+17%	+$1.91M	0.14%	142
2024 Q1	$9.89M	Buy	72,971 +2,615	+4%	+$346K	0.11%	200
2023 Q4	$9.74M	Buy	70,356 +6,802	+11%	+$884K	0.11%	181
2023 Q3	$8.61M	Buy	63,554 +15,209	+31%	+$2.08M	0.1%	192
2023 Q2	$6.92M	Sell	48,345 -10,858	-18%	-$1.6M	0.07%	256
2023 Q1	$8.22M	Buy	59,203 +53,249	+894%	+$7.16M	0.1%	185
2022 Q4	$807K	Buy	5,954 +507	+9%	+$63.6K	0.03%	367
2022 Q3	$597K	Buy	5,447 +207	+4%	+$26.3K	0.02%	372
2022 Q2	$692K	Sell	5,240 -25	-0.5%	-$3.28K	0.03%	326
2022 Q1	$698K	Buy	+5,265	New	+$631K	0.02%	341
2021 Q4	–	Sell	-1,743	Closed	-$209K	–	699
2021 Q3	$209K	Buy	+1,743	New	+$203K	0.01%	618
2020 Q3	–	Sell	-372	Closed	-$39K	–	563
2020 Q2	$39K	Hold	372	–	–	﹤0.01%	766
2020 Q1	$33K	Sell	372 -24	-6%	-$2.26K	﹤0.01%	688
2019 Q4	$39K	Buy	+396	New	+$37.3K	﹤0.01%	600

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Orion Portfolio Solutions's AZN Position: Q1 2025 in Review

Orion Portfolio Solutions increased its AstraZeneca (AZN) stake by 0.22% in Q1 2025, buying an estimated $23.7K and bringing the position to 74,749 shares worth $11M. The position accounts for 0.11% of the portfolio, ranked #175.

Orion Portfolio Solutions first reported a position in AZN in Q4 2019 and has held it in 17 quarters since. The position peaked at $13.4M in Q2 2024. 1,249 funds tracked by Wall St. Rank hold AZN as of Q1 2025.

Orion Portfolio Solutions held 74,749 shares of AstraZeneca worth $11M as of Q1 2025.
Orion Portfolio Solutions bought 164 AstraZeneca shares in Q1 2025, an estimated $23.7K.
AstraZeneca made up 0.11% of Orion Portfolio Solutions's portfolio in Q1 2025, its #175 holding.
Orion Portfolio Solutions first reported a position in AstraZeneca in Q4 2019 and has held it in 17 quarters since.
Orion Portfolio Solutions's AstraZeneca position peaked at $13.4M in Q2 2024.
1,249 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.